SCHEMBL2807324

SCHEMBL2807324

O=C(O)CSCCCCCSCC(=O)O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.77
GMNN O75496 1/20 0.77
TP53 P04637 1/20 0.77
POLB P06746 1/20 0.77
MAPT P10636 1/20 0.77
THRB P10828 1/20 0.77
CYP2C9 P11712 1/20 0.77
BLM P54132 1/20 0.77
CYP2D6 P10635 2/20 0.61
HIF1A Q16665 1/20 0.61
CES2 O00748 3/20 0.50
CYP2C19 P33261 1/20 0.45
BHMT Q93088 2/20 0.45
FAAH O00519 4/20 0.43
CES1 P23141 4/20 0.43
PLA2G6 O60733 1/20 0.43
TSHR P16473 2/20 0.42
LMNA P02545 2/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5597990 1.00 HSD17B10 (0.77) HSD17B10GMNNTP53POLBMAPT
SCHEMBL6231607 1.00 HSD17B10 (0.77) HSD17B10GMNNTP53POLBMAPT
SCHEMBL22921976 0.97 HSD17B10 (0.74) HSD17B10GMNNTP53POLBMAPT
SCHEMBL8666564 0.97 HSD17B10 (0.73) HSD17B10GMNNTP53POLBMAPT
Hydrochloric Acid SCHEMBL11144143 0.94 HSD17B10 (0.70) HSD17B10GMNNTP53POLBMAPT
SCHEMBL22922013 0.94 HSD17B10 (0.70) HSD17B10GMNNTP53POLBMAPT
SCHEMBL15282760 0.91 HSD17B10 (0.65) HSD17B10GMNNTP53POLBMAPT
SCHEMBL8025679 0.90 THRB (0.65) HSD17B10GMNNTP53POLBMAPT
SCHEMBL10604063 0.90 GMNN (0.65) HSD17B10GMNNTP53POLBMAPT
SCHEMBL6866607 0.90 THRB (0.65) HSD17B10GMNNTP53POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8968711-B2 Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process L'OREAL (FR) 2015-03-03 US claimed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US claimed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US claimed
EP-4204100-A1 HAIR LIGHTENING COMPOSITIONS PROVIDING DAMAGE PROTECTION AND SENSORIAL BENEFITS AND METHODS OF USE L'OREAL (FR) 2023-07-05 EP disclosed
CN-116322616-A Hair lightening compositions providing damage protection and sensory benefits and methods of use 欧莱雅 2023-06-23 CN disclosed
US-11559474-B2 Hair lightening compositions and methods of use L'OREAL (FR) 2023-01-24 US disclosed
WO-2022047081-A1 HAIR LIGHTENING COMPOSITIONS PROVIDING DAMAGE PROTECTION AND SENSORIAL BENEFITS AND METHODS OF USE HENRY DEREK (US) 2022-03-03 WO disclosed
WO-2018119500-A1 VISCOELASTIC COSMETIC COMPOSITIONS L'OREAL (FR) 2018-07-05 WO disclosed
US-8968711-B2 Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process L'OREAL (FR) 2015-03-03 US disclosed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US disclosed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US disclosed
US-20090028807-A1 COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION L'OREAL (FR) 2009-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS CUTA, SUCLG1, KRT18 HSD17B10 71/4885GMNN 3959/4885TP53 964/4885
US-20090028807-A1 COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION CUTA, SYMPK, TPRKB HSD17B10 2366/4885GMNN 1252/4885TP53 1857/4885
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT ACMSD, CUTA, PCCA HSD17B10 47/4885GMNN 2750/4885TP53 1009/4885
US-11559474-B2 Hair lightening compositions and methods of use TYR, ALAD, CYBA HSD17B10 671/4885GMNN 4131/4885TP53 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.